|Day's Range||131.16 - 131.45|
|52 Week Range||106.87 - 131.45|
|PE Ratio (TTM)||64.72|
|Expense Ratio (net)||0.06%|
Given Apple's stock outperformance this year, it's not surprising to see it at the top of many equity growth funds' holdings.
These two ETF picks are at the top of their flat bases and in buy range from a 50-day rebound.
On June 27, 2017, Thermo Fisher Scientific announced the launch of its Oncomine Dx Target Test.